Mesoblast Limited (MESO) has been flagged as one of the top long-term picks among ASX-listed stocks, drawing attention from investors scanning for durable growth opportunities. The Australian biotech, which trades on both the ASX and Nasdaq, operates in the cell therapy space with a pipeline centered on its mesenchymal stromal cell platform. The designation as a best long-term buy signals analyst or institutional confidence in the company's multi-year trajectory rather than near-term catalysts. Mesoblast's commercial and regulatory progress, particularly around its lead product remestemcel-L, has been a core driver of investor interest. The cell therapy sector broadly carries high binary risk tied to clinical trial outcomes and regulatory decisions, meaning long-term conviction requires tolerance for milestone-driven volatility. Investors tracking MESO should monitor pipeline readouts, FDA interactions, and any partnership or licensing developments that could materially shift the company's funding runway and revenue visibility.
The Indian government has launched an OFS to sell up to 6.5% of its LIC stake, opening for non-retail investors on August 4, 2026, at a floor price of Rs 382 per share, about 11% below Monday's close. The discounted offering is likely to pressure LIC shares in the near term as supply increases sharply.
More than a dozen major Indian companies including Bharti Airtel, ONGC, Pidilite, Nykaa, DLF, and Ather Energy report April-June 2026 earnings on August 4. Results span telecom, energy, consumer goods, real estate, and EV sectors, giving markets a broad read on corporate health mid-earnings season.
Amazon shares hit a new all-time high Monday, pushing its market cap above $3 trillion following a sustained post-earnings rally. The milestone places Amazon among the very few companies globally to reach this valuation, with investor focus on AWS and advertising growth driving the move.
Sensex Gains 500 Points as Oil Falls on Iran Talks
The Sensex rose around 500 points and the Nifty crossed 24,500 on Monday after Donald Trump announced talks with Iran, pushing oil prices lower. IndiGo, ITC, FMCG, and metals led the gains as cheaper crude eased cost and inflation concerns.
